Namita Thapar: net worth, Emcure Pharma and Shark Tank India deals
Namita Thapar built Emcure Pharma and has taken a chair in every season of Shark Tank India so far. The figures below are the publicly reported estimates on record as of September 2026, in crore rupees.
55 finalised investments put Namita Thapar 3rd of the 16 Indian investors whose deal count is on record — 24% of everything the standing panel has backed. On personal net worth the estimate of ₹600 Cr ranks 10th of 19. Emcure Pharma at around ₹20,000 Cr is the 4th largest business on the Shark Tank India roster. Personal net worth and the value of the company behind someone are different questions, and conflating them is the most common mistake made with these numbers.
The record
What this page does not say
It does not list the pitches Namita Thapar personally invested in. Our pitch records come from the tables in Wikipedia's season articles, and the per-shark columns in those tables use spanned rows that cannot be read back to a named investor reliably. Attributing someone else's deal to Namita Thapar, or missing one of theirs, is not a rounding error on a page about a real person, so the column is left out of our data entirely rather than guessed at. The 55-deal count above is the total a published source states, not something we counted.
Net worth and valuation are publicly reported estimates gathered from press coverage as of September 2026, not figures we have audited, and most of the people listed do not disclose either. Indian figures are in crore rupees and US figures in US dollars; the two are never mixed. All 21 Indian investors are compared side by side on the judges hub. Spotted something wrong? Send a correction with a source and we publish within 48 hours.